IMDX 424B5: Secondary offering

Insight Molecular Diagnostics Inc.

Filed with the SEC on · accession 0001493152-26-052499

IMDX filed a 424B5 (prospectus (offering)) with the SEC on Nov 16, 2026. Insight Molecular Diagnostics Inc. (IMDX) filed a preliminary prospectus supplement for an underwritten public offering of common stock and pre-funded warrants, with Lake Street Capital Markets as sole underwriter. The stock moved -13.1% by the first close after the filing.

Summary of the filing

Insight Molecular Diagnostics Inc. (IMDX) filed a preliminary prospectus supplement for an underwritten public offering of common stock and pre-funded warrants, with Lake Street Capital Markets as sole underwriter. The offering price, share count, and total value are not yet specified in this preliminary filing.

Key details

IssuerInsight Molecular Diagnostics Inc.
Sole underwriterLake Street Capital Markets, LLC

How IMDX stock reacted

Close before

$2.14

Nov 13, 2026

First close after

-13.08%

$1.86

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for IMDX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for IMDX?

Click here

Frequently asked questions

What did IMDX file with the SEC on Nov 16, 2026?

IMDX filed a 424B5 (Secondary offering). Insight Molecular Diagnostics Inc. (IMDX) filed a preliminary prospectus supplement for an underwritten public offering of common stock and pre-funded warrants, with Lake Street Capital Markets as sole underwriter. The offering price, share count, and total value are not yet specified in this preliminary filing.

What does a secondary offering mean for IMDX stock?

New shares dilute existing holders and are often sold at a discount to the market price.

How do I read a 424B5?

The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B5 (prospectus (offering)): The final terms of an offering of shares or bonds.

How did IMDX stock react to this filing?

IMDX closed at $2.14 before the filing and $1.86 on Nov 16, 2026 (-13.08%).

Other IMDX SEC filings

Get alerts when IMDX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days